HK1214600A1 - 種含磷吡啶並 嘧啶- -酮類化合物或其藥學上可接受的鹽、藥物組合物及其應用 - Google Patents

種含磷吡啶並 嘧啶- -酮類化合物或其藥學上可接受的鹽、藥物組合物及其應用

Info

Publication number
HK1214600A1
HK1214600A1 HK16102474.3A HK16102474A HK1214600A1 HK 1214600 A1 HK1214600 A1 HK 1214600A1 HK 16102474 A HK16102474 A HK 16102474A HK 1214600 A1 HK1214600 A1 HK 1214600A1
Authority
HK
Hong Kong
Prior art keywords
pyrimidin
phosphorus
ones
compound
pharmaceutically acceptable
Prior art date
Application number
HK16102474.3A
Other languages
English (en)
Inventor
呂慧敏
Original Assignee
Shandong Huiruidi Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Huiruidi Biotechnology Co Ltd filed Critical Shandong Huiruidi Biotechnology Co Ltd
Publication of HK1214600A1 publication Critical patent/HK1214600A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK16102474.3A 2014-08-13 2016-03-03 種含磷吡啶並 嘧啶- -酮類化合物或其藥學上可接受的鹽、藥物組合物及其應用 HK1214600A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410397283.8A CN105330699B (zh) 2014-08-13 2014-08-13 一种含磷吡啶并[2,3-d]嘧啶-7-酮类化合物或其药学上可接受的盐、药物组合物及其应用

Publications (1)

Publication Number Publication Date
HK1214600A1 true HK1214600A1 (zh) 2016-07-29

Family

ID=55281487

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16102474.3A HK1214600A1 (zh) 2014-08-13 2016-03-03 種含磷吡啶並 嘧啶- -酮類化合物或其藥學上可接受的鹽、藥物組合物及其應用

Country Status (4)

Country Link
CN (1) CN105330699B (zh)
HK (1) HK1214600A1 (zh)
TW (1) TW201605882A (zh)
WO (1) WO2016023401A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106905315B (zh) * 2017-03-02 2019-09-27 北京工业大学 四氢吡啶并[3,4-d]嘧啶类化合物及其制备方法和应用
CN109280014A (zh) * 2018-09-05 2019-01-29 成都百事兴科技实业有限公司 反式-4-氨基-环己甲酸乙酯盐酸盐的制备方法
WO2021139775A1 (zh) * 2020-01-10 2021-07-15 江苏先声药业有限公司 吡啶酮化合物及应用
KR20230121758A (ko) 2020-11-18 2023-08-21 데시페라 파마슈티칼스, 엘엘씨. Gcn2 및 perk 키나제 억제제 및 그의 사용 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4758349B2 (ja) * 2003-10-08 2011-08-24 アイアールエム・リミテッド・ライアビリティ・カンパニー タンパク質キナーゼ阻害剤としての化合物および組成物
HUE030950T2 (en) * 2004-05-13 2017-06-28 Icos Corp Quinazolinones as 3-kinase delta inhibitors of human phosphatidylinositol
GB0510390D0 (en) * 2005-05-20 2005-06-29 Novartis Ag Organic compounds
JO2660B1 (en) * 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
JP4718637B2 (ja) * 2006-09-15 2011-07-06 ファイザー・プロダクツ・インク ピリド（２，３−ｄ）ピリミジノン化合物およびｐｉ３阻害剤としてのその使用
PE20090717A1 (es) * 2007-05-18 2009-07-18 Smithkline Beecham Corp Derivados de quinolina como inhibidores de la pi3 quinasa
AU2011255218B2 (en) * 2010-05-21 2015-03-12 Infinity Pharmaceuticals, Inc. Chemical compounds, compositions and methods for kinase modulation
US9295673B2 (en) * 2011-02-23 2016-03-29 Intellikine Llc Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof
MX2013011518A (es) * 2011-04-08 2014-06-04 Afraxis Holdings Inc 8-etil-6-(aril)pirido[2,3-d]pirimidin-7(8h)-onas para el tratamiento de desordenes del sistema nervioso y cancer.

Also Published As

Publication number Publication date
WO2016023401A1 (zh) 2016-02-18
TW201605882A (zh) 2016-02-16
CN105330699A (zh) 2016-02-17
CN105330699B (zh) 2018-12-04

Similar Documents

Publication Publication Date Title
IL250158A0 (en) History of naphthyridine and isoquinoline, their preparation and pharmaceutical preparations containing them
PL3674298T3 (pl) Nowe podstawione indazole, sposób ich wytwarzania, preparaty farmaceutyczne je zawierające, oraz ich zastosowanie do wytwarzania leków
HK1231416A1 (zh) 西羅莫司及其衍生物的絡合物、其製備方法以及含有其的藥物組合物
ZA201705112B (en) Salt of a pyrimido[6,1-a]isoquinolin-4-one compound
HK1247203A1 (zh) 取代的咪唑並[1，2-α]吡啶-2-基胺化合物及其藥物組合物和使用方法
IL250267A0 (en) History of indolizine, their preparation and pharmaceutical preparations containing them
IL273740A (en) Oral pharmaceutical formulation containing bacteria
PT3421038T (pt) Compostos de naftiridina, combinações médicas e sua utilização
IL262204A (en) Granular formulation for oral administration
HK1255313A1 (zh) 含有培美曲塞或其藥學上可接受的鹽的穩定藥物組合物
HK1214600A1 (zh) 種含磷吡啶並 嘧啶- -酮類化合物或其藥學上可接受的鹽、藥物組合物及其應用
HK1243351A1 (zh) 一種含有吡啶並嘧啶類衍生物或其可藥用鹽的藥物組合物
HUP1400104A2 (en) Compositions comprising indometacine, its pharmaceutically acceptable salts and cocrystals; and process for the preparation
HUP1600415A2 (en) Pimavanserin salts for the manufacture of pharmaceutical formulations
EP3227292A4 (en) 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS
EP3162368A4 (en) Pharmaceutical composition for oral administration
ZA201803722B (en) Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof
EP3222271A4 (en) Stable pharmaceutical composition comprising pemetrexed or pharmaceutically acceptable salt thereof
HUP1600436A2 (en) Salts for the preparation of a pharmaceutical composition
HUP1400520A2 (hu) Gyógyászati készítmény elõállítására alkalmazható laquinimod sók
HUP1400105A2 (hu) Nanostrukturált ibuprofent, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás elõállításukra
AU2014904868A0 (en) 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS
HUP1400103A2 (en) Compositions comprising nanostructured rosuvastatin, its pharmaceutically acceptable salts and cocrystals and process for the preparation